https://biotechmorning.com/news/neomorph-100m-molecular-glue-degrader Biotech Morning en 2026-04-14T14:13:46.875Z The $100M Bet on Drugs That Work Like Superglue https://biotechmorning.com/news/kailera-therapeutics-ipo-obesity-drugs Biotech Morning en 2026-04-14T14:13:05.406Z The $528M Bet That Obesity Drugs Still Have Room for One More https://biotechmorning.com/news/big-pharma-immunology-spring-cleaning-2 Biotech Morning en 2026-04-14T14:12:20.806Z Big Pharma's Immunology Spring Cleaning Has Begun https://biotechmorning.com/news/alamar-biosciences-ipo-billion-dollar-valuation Biotech Morning en 2026-04-14T14:11:35.666Z The Protein Company That Tripled Revenue Wants a Billion-Dollar Valuation https://biotechmorning.com/news/abbvie-745m-haisco-pain-deal Biotech Morning en 2026-04-14T14:10:50.119Z AbbVie's $745M Bet That Pain Relief Doesn't Need Opioids https://biotechmorning.com/news/lilly-300m-crossbridge-bio-adc-acquisition Biotech Morning en 2026-04-14T14:10:05.057Z Lilly's $300M Bet on a Biotech That Doesn't Even Have a Drug in Humans Yet https://biotechmorning.com/news/gsk-adc-phase-3-gynecologic-cancer Biotech Morning en 2026-04-13T14:15:08.758Z GSK's $31 Billion Bet Starts With a Cancer Most Companies Won't Touch https://biotechmorning.com/news/big-pharma-immunology-spring-cleaning Biotech Morning en 2026-04-13T14:14:23.300Z Big Pharma's Immunology Spring Cleaning Has Begun https://biotechmorning.com/news/regeneron-telix-radiopharmaceutical-deal Biotech Morning en 2026-04-13T14:13:44.037Z Regeneron Just Crashed the Hottest Party in Oncology https://biotechmorning.com/news/sclc-ifinatamab-deruxtecan-priority-review Biotech Morning en 2026-04-13T14:12:56.154Z The Cancer That Kills Fast Just Met a Drug That Moves Faster https://biotechmorning.com/news/allogene-off-the-shelf-car-t-lymphoma-results Biotech Morning en 2026-04-13T14:12:07.005Z The $10K Cancer Therapy That Just Passed Its Biggest Test https://biotechmorning.com/news/eye-cancer-uveal-melanoma-ideaya-darovasertib-fda Biotech Morning en 2026-04-13T14:11:14.474Z The Eye Cancer That Finally Got a Real Drug https://biotechmorning.com/news/seaport-hemab-ipo-filings-same-day Biotech Morning en 2026-04-13T14:10:31.528Z Two Biotechs Just Rang the IPO Bell on the Same Day https://biotechmorning.com/news/ras-undruggable-target-revolution-medicines-phase-3-win Biotech Morning en 2026-04-13T14:09:42.450Z The Protein That Stumped Cancer Researchers for 40 Years Just Lost